Multimodality molecular imaging: Paving the way for personalized medicine
Early diagnosis and therapy increasingly operate at the cellular, molecular or even at the genetic level. As diagnostic techniques transition from the systems to the molecular level, the role of multimodality molecular imaging becomes increasingly important. Positron emission tomography (PET), x-ray CT and MRI are powerful techniques for in vivo imaging. The inability of PET to provide anatomical information is a major limitation of standalone PET systems. Combining PET and CT proved to be clinically relevant and successfully reduced this limitation by providing the anatomical information required for localization of metabolic abnormalities. However, this technology still lacks the excellent soft-tissue contrast provided by MRI. Standalone MRI systems reveal structure and function, but cannot provide insight into the physiology and/or the pathology at the molecular level. The combination of PET and MRI, enabling truly simultaneous acquisition, bridges the gap between molecular and systems diagnosis. MRI and PET offer richly complementary functionality and sensitivity; fusion into a combined system offering simultaneous acquisition will capitalize the strengths of each, providing a hybrid technology that is greatly superior to the sum of its parts.
This talk also reflects the tremendous increase in interest in quantitative molecular imaging using PET as both clinical and research imaging modality in the past decade. It offers a brief overview of the entire range of quantitative PET imaging from basic principles to various steps required for obtaining quantitatively accurate data from dedicated standalone PET and combined PET/CT and PET/MR systems including algorithms used to correct for physical degrading factors and to quantify tracer uptake and volume for radiation therapy treatment planning. Future opportunities and the challenges facing the adoption of multimodality imaging technologies and their role in biomedical research will also be addressed.
2. Mehranian A, Arabi H and Zaidi H "Vision 20/20: Magnetic resonance imaging-guided attenuation correction in PET/MRI: Challenges, solutions and opportunities" Med Phys Vol. 43, No. 3, pp 1130-1155 (2016). https://doi.org/10.1118/1.4941014 PMid:26936700
3. Zaidi H et al "PET performance of the Ingenuity TF PET-MR: a whole body PET-MRI system" Phys Med Biol Vol. 56, No. 10, pp 3091-3106 (2011). https://doi.org/10.1088/0031-9155/56/10/013 PMid:21508443 MCid:PMC4059360
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.